Literature DB >> 16421600

Genetic design of an optimized packaging cell line for gene vectors transducing human B cells.

E Hettich1, A Janz, R Zeidler, D Pich, E Hellebrand, B Weissflog, A Moosmann, W Hammerschmidt.   

Abstract

Viral gene vectors often rely on packaging cell lines, which provide the necessary factors in trans for the formation of virus-like particles. Previously, we reported on a first-generation packaging cell line for gene vectors, which are based on the B-lymphotropic Epstein-Barr virus (EBV), a human gamma-herpesvirus. This 293HEK-derived packaging cell line harbors a helper virus genome with a genetic modification that prevents the release of helper virions, but efficiently packages vector plasmids into virus-like particles with transducing capacity for human B cells. Here, we extended this basic approach towards a non-transforming, virus-free packaging cell line, which harbors an EBV helper virus genome with seven genetic alterations. In addition, we constructed a novel gene vector plasmid, which is devoid of a prokaryotic antibiotic resistance gene, and thus more suitable for in vivo applications in human gene therapy. We demonstrate in this paper that EBV-based gene vectors can be efficiently generated with this much-improved packaging cell line to provide helper virus-free gene vector stocks with transducing capacity for established human B-cell lines and primary B cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16421600     DOI: 10.1038/sj.gt.3302714

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  7 in total

Review 1.  Herpesviral vectors and their application in oncolytic therapy, vaccination, and gene transfer.

Authors:  Susanne M Bailer; Christina Funk; André Riedl; Zsolt Ruzsics
Journal:  Virus Genes       Date:  2017-06-20       Impact factor: 2.332

2.  RNAs in Epstein-Barr virions control early steps of infection.

Authors:  Simon Jochum; Romana Ruiss; Andreas Moosmann; Wolfgang Hammerschmidt; Reinhard Zeidler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-27       Impact factor: 11.205

3.  A virus-like particle-based Epstein-Barr virus vaccine.

Authors:  Romana Ruiss; Simon Jochum; Gerhard Wanner; Gilbert Reisbach; Wolfgang Hammerschmidt; Reinhard Zeidler
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

Review 4.  Herpesvirus BACs: past, present, and future.

Authors:  Charles Warden; Qiyi Tang; Hua Zhu
Journal:  J Biomed Biotechnol       Date:  2010-10-27

5.  First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus.

Authors:  Dagmar Pich; Paulina Mrozek-Gorska; Mickaël Bouvet; Atsuko Sugimoto; Ezgi Akidil; Adam Grundhoff; Stephan Hamperl; Paul D Ling; Wolfgang Hammerschmidt
Journal:  mBio       Date:  2019-09-17       Impact factor: 7.867

Review 6.  The Status and Prospects of Epstein-Barr Virus Prophylactic Vaccine Development.

Authors:  Cong Sun; Xin-Chun Chen; Yin-Feng Kang; Mu-Sheng Zeng
Journal:  Front Immunol       Date:  2021-06-08       Impact factor: 7.561

7.  Conditional gene vectors regulated in cis.

Authors:  Dagmar Pich; Sibille Humme; Mark-Peter Spindler; Aloys Schepers; Wolfgang Hammerschmidt
Journal:  Nucleic Acids Res       Date:  2008-06-19       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.